Cargando…

Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns

Detalles Bibliográficos
Autores principales:	Foley, K. A., Song, X.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911203/ https://www.ncbi.nlm.nih.gov/pubmed/32634899 http://dx.doi.org/10.1093/annonc/mdq329

Ejemplares similares

Reply: Cetuximab in small bowel adenocarcinoma: a new friend?
por: Overman, M J, et al.
Publicado: (2010)

Claiming Positive Results From Negative Trials: A Cause for Concern in Randomized Controlled Trial Research - Author's Reply
por: Hester, Reid, et al.
Publicado: (2013)

Reply to “raised concern”
por: JOHANNING, Eckardt, et al.
Publicado: (2021)

Authors’ Reply: Concerns on Generalizability
por: Chung, Hsueh-Wen, et al.
Publicado: (2023)

Concerns about the interpretation of subgroup analysis. Reply.
por: Li, Shilong, et al.
Publicado: (2022)

Concerns about Continuing Claims that a Protein Complex Interacts with the Phosphorelay
por: Losick, Richard
Publicado: (2020)

Reply: Concerns with the use of Genelyn cadavers for surgical simulation
por: Loh, Charles Yuen Yung, et al.
Publicado: (2016)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

Response Letter Concerning: Correctly Identify Practitioners and Put Adverse Events of Spinal Manipulation into Perspective
por: Struewer, Johannes, et al.
Publicado: (2014)

Reply to “Methodological notes, should be considered in research on Mizaj”
por: Aghanouri, Zahra, et al.
Publicado: (2021)

In Reply: Revisiting Claims of the Continued Absence of Functional Germline Stem Cells in Adult Ovaries
por: Yoshihara, Masahito, et al.
Publicado: (2022)

Reply: Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System
por: Cameron, Alan C., et al.
Publicado: (2021)

Author's reply to concern on excessive dynamic airway collapse and wheeze
por: Sindhwani, Girish, et al.
Publicado: (2017)

Concerns over functional experiments, interpretation, and required controls. Reply.
por: Hsieh, Wan-Chen, et al.
Publicado: (2022)

‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ – Author’s reply
por: Wolkewitz, Martin, et al.
Publicado: (2021)

Reply: Long-Term Survival and Adverse Events in Cardiac Sarcoidosis
por: Kusano, Kengo, et al.
Publicado: (2022)

Reply to “Tachycardia, adverse effect, COVID-19 vaccine”
por: Teresa Marco García, M., et al.
Publicado: (2023)

Methodological considerations in studying psycho-social aspects of suicide: Reply to the criticism
por: Kumar, P. N. Suresh, et al.
Publicado: (2014)

Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database
por: Picaut, Philippe
Publicado: (2018)

Reply to “Concerns about Recently Identified Widespread Antisense Transcription in Escherichia coli”
por: Wade, Joseph T., et al.
Publicado: (2010)

Reply from author for letter to the editor concerning: Stroke and diets: A review
por: Lin, Chin-Lon
Publicado: (2021)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors’ Reply
por: Kang, Yewon, et al.
Publicado: (2022)

Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System”
por: Trumbo, Henry, et al.
Publicado: (2021)

Reply to: Austin et al. CytoJournal 2009;6:12 (Unfounded claims mar scientific critique)
por: Jeronimo, Jose, et al.
Publicado: (2009)

Claiming Positive Results From Negative Trials: A Cause for Concern in Randomized Controlled Trial Research
por: Cunningham, John A
Publicado: (2013)

A Framework for Conducting Meta-analysis Studies; Methodological Concerns and Recommendations
por: ARYANKHESAL, Aidin, et al.
Publicado: (2018)

Authors’ Reply: Methodological Considerations for a Diabetes Family-Based eHealth Intervention
por: Feng, Yuheng, et al.
Publicado: (2023)

Primary chemoradiation with cisplatin versus cetuximab for locally advanced head and neck cancer: a retrospective cohort study
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

Cetuximab in small bowel adenocarcinoma: a new friend?
por: Santini, D, et al.
Publicado: (2010)

Cetuximab-induced esophageal ulcer: the first report in literature
por: Babacan, Taner, et al.
Publicado: (2014)

Author’s Reply to: Comment on “Web-Based Measure of Life Events Using Computerized Life Events and Assessment Record (CLEAR): Preliminary Cross-Sectional Study of Reliability, Validity, and Association With Depression”: Validity and Methodological Issues
por: Bifulco, Antonia
Publicado: (2020)

Reply to comments and questions of Dr. Correale et al. about our review concerning CTEPH
por: Schölzel, Bastiaan E., et al.
Publicado: (2015)

Reply - Letter to the editor: “Micronutrient supplementation, COVID-19 vaccination and adverse effect”
por: Dalan, Rinkoo, et al.
Publicado: (2022)

Coronavirus disease pandemic and dry eye disease: A methodology concern on the causal relationship
por: Al-Namaeh, Mashael
Publicado: (2022)

Reply: Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib
por: Mickisch, G H J, et al.
Publicado: (2010)

Authors’ Reply to Mungmunpuntipantip et al.’s Comment on “Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands”
por: Kant, Agnes, et al.
Publicado: (2022)

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk. Reply.
por: Choi, Won-Mook, et al.
Publicado: (2022)

Methodological Concerns Regarding Levels of Vascular Endothelial Growth Factor (VEGF) in Serum of Women with Endometriosis
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2015)

Reply 1: Call for NICE to review urgently their guidance concerning first-line chemotherapy for metastatic colorectal cancer
por: Saunders, M P, et al.
Publicado: (2003)

Reply to the editorial comment from Van der Wall concerning ‘The right ventricle: always normal in normal subjects?’
por: Quick, S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_03dob63vi5v3j7hq00lfqnkqhd